Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Merck (NYSE: MRK) to acquire Cidara (NASDAQ: CDTX) for $9.2 billion, diversifying its portfolio with CD388.
https://www.ft.com/content/743e1962-3dd1-4785-a20b-4b097e5514ae
https://www.ft.com/content/743e1962-3dd1-4785-a20b-4b097e5514ae
TotalEnergies and Google have signed a 15-year PPA for renewable electricity. The deal aligns with both companies' goals.
Enlicitide has the potential to be the first approved oral PCSK9 inhibitor designed to deliver antibody-like efficacy and help ...
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced today that the company has entered into an ag...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the company, through a subsidiary...
